A preliminary communication on the use of cephacetrile as monotherapy in the treatment of purulent meningitis.
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008875:Middle Aged; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use
D000081:Acetamides; D002511:Cephalosporins; D009570:Nitriles; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase